 <h1>Capozide 50 / 15 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>captopril / hydrochlorothiazide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about captopril / hydrochlorothiazide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Capozide 50 / 15.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to captopril/hydrochlorothiazide: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Use in PregnancyWhen used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, captopril and hydrochlorothiazide should be discontinued as soon as possible.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, captopril / hydrochlorothiazide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking captopril / hydrochlorothiazide:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>fever</li>
<li>painful or difficult urination</li>
<li>shortness of breath</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on lips or in mouth</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>cloudy urine</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>sweating</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Arm, back or jaw pain or discomfort</li>
<li>bloody urine</li>
<li>chest discomfort</li>
<li>chest tightness or heaviness</li>
<li>decreased blood pressure</li>
<li>decreased frequency or amount of urine</li>
<li>dilated neck veins</li>
<li>increased need to urinate</li>
<li>increased thirst</li>
<li>irregular breathing</li>
<li>large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>paleness or cold feeling in fingertips and toes</li>
<li>passing urine more often</li>
<li>problems in urination or increase in amount of urine</li>
<li>swelling of face, fingers, feet or lower legs</li>
<li>tingling or pain in fingers or toes when exposed to cold</li>
<li>troubled breathing</li>
<li>vomiting</li>
<li>weight gain</li>
<li>wheezing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of captopril / hydrochlorothiazide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty in moving</li>
<li>itching skin</li>
<li>muscle pain or stiffness</li>
<li>pain in joints</li>
<li>rash</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in taste</li>
<li>loss of taste</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to captopril / hydrochlorothiazide: oral tablet</i></p><h3>Gastrointestinal</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Nausea, vomiting, gastric irritations, abdominal pain, diarrhea, constipation, dry mouth, peptic ulcer, aphthous ulcers</p>
<p><b>Rare</b> (0.01% to 0.1%): Intestinal angioedema</p>
<p><b>Very rare</b> (less than 0.01%): Glossitis, pancreatitis</p>
<p><b>Frequency not reported</b>: Dyspepsia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Sialadenitis, gastric irritation, diarrhea, constipation, pancreatitis, cramping, nausea, vomiting<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Taste impairment, dizziness, headache, paresthesias</p>
<p><b>Rare</b> (0.01% to 0.1%): Drowsiness</p>
<p><b>Very rare</b> (less than 0.01%): Cerebrovascular incidents</p>
<p><b>Frequency not reported</b>: Syncope, ataxia, somnolence</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Paresthesia, lightheadedness, vertigo, dizziness, headache<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Pruritus, rash, alopecia</p>
<p><b>Uncommon</b> (0.1% to 1%): Angioedema</p>
<p><b>Very rare</b> (less than 0.01%): Urticaria, Stevens-Johnson syndrome, erythema multiforme, photosensitivity, pemphigoid reactions, erythroderma, exfoliative dermatitis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Cutaneous vasculitis, photosensitivity reactions, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, urticaria, toxic epidermal necrolysis, purpura<sup>[Ref]</sup></p><h3>Other</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Chest pain, malaise, fatigue</p>
<p><b>Very rare</b> (less than 0.01%): Gynecomastia, fever</p>
<p><b>Frequency not reported</b>: Asthenia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Fever, weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Tachycardia, palpitations</p>
<p><b>Uncommon</b> (0.1% to 1%): Tachyarrhythmia, angina pectoris, hypotension, Raynaud's syndrome, flush, pallor, myocardial infarction, congestive heart failure</p>
<p><b>Very rare</b> (less than 0.01%): Cardiac arrest, cardiogenic shock</p>
<p><b>Frequency not reported</b>: Rhythm disturbances, orthostatic hypotension</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Postural hypotension, cardiac arrhythmias, vasculitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Cough, dyspnea</p>
<p><b>Very rare</b> (less than 0.01%): Bronchospasm, rhinitis, allergic alveolitis/eosinophilic pneumonia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Sleep disorders, insomnia</p>
<p><b>Very rare</b> (less than 0.01%): Confusion, depression</p>
<p><b>Frequency not reported</b>: Nervousness</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Restlessness, depression, sleep disturbances<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Proteinuria</p>
<p><b>Uncommon</b> (0.1% to 1%): Polyuria, oliguria, urinary frequency</p>
<p><b>Very rare</b> (less than 0.01%): Impotence</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Glycosuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Captopril:</p>
<p><b>Common</b> (1% to 10%): Anorexia</p>
<p><b>Very rare</b> (less than 0.01%): Hyperkalemia, hypoglycemia, serum potassium increased, serum sodium decreased</p>
<p><b>Frequency not reported</b>: Symptomatic hyponatremia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anorexia, hyperglycemia, hyperuricemia, electrolyte imbalance, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased, loss of appetite<sup>[Ref]</sup></p><h3>Renal</h3><p>Captopril:</p>
<p><b>Uncommon</b> (0.1% to 1%): Renal insufficiency, renal failure, nephrotic syndrome</p>
<p><b>Very rare</b> (less than 0.01%): BUN increased, serum creatinine increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Renal dysfunction, interstitial nephritis<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Captopril:</p>
<p><b>Uncommon</b> (0.1% to 1%): Eosinophilia</p>
<p><b>Very rare</b> (less than 0.01%): Neutropenia/agranulocytosis, pancytopenia, anemia, thrombocytopenia, lymphadenopathy, hemoglobin decreased, hematocrit decreased, leukocytes decreased, thrombocytes decreased, erythrocyte sedimentation rate increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Leukopenia, neutropenia/agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, bone marrow depression<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Captopril:</p>
<p><b>Uncommon</b> (0.1% to 1%): Antinuclear antibody positive</p>
<p><b>Very rare</b> (less than 0.01%): Autoimmune diseases</p>
<p><b>Frequency not reported</b>: Anaphylactoid reactions</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Captopril:</p>
<p><b>Very rare</b> (less than 0.01%): Impaired hepatic function and cholestasis including jaundice, hepatitis including necrosis, elevated liver enzymes and bilirubin</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Captopril:</p>
<p><b>Very rare</b> (less than 0.01%): Myalgia, arthralgia</p>
<p><b>Frequency not reported</b>: Myasthenia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Ocular</h3><p>Captopril:</p>
<p><b>Very rare</b> (less than 0.01%): Blurred vision</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Xanthopsia, transient blurred vision, acute myopia, secondary acute angle-closure glaucoma<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Capozide (hydrochlorothiazide-captopril)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Capozide 50 / 15 (captopril / hydrochlorothiazide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: ACE inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Capozide 25/15, Capozide 25/25, Capozide 50/25</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Heart Failure</li>
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to captopril / hydrochlorothiazide: oral tablet</i></p><h3>Gastrointestinal</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Nausea, vomiting, gastric irritations, abdominal pain, diarrhea, constipation, dry mouth, peptic ulcer, aphthous ulcers</p><p><b>Rare</b> (0.01% to 0.1%): Intestinal angioedema</p><p><b>Very rare</b> (less than 0.01%): Glossitis, pancreatitis</p><p><b>Frequency not reported</b>: Dyspepsia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Sialadenitis, gastric irritation, diarrhea, constipation, pancreatitis, cramping, nausea, vomiting<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Taste impairment, dizziness, headache, paresthesias</p><p><b>Rare</b> (0.01% to 0.1%): Drowsiness</p><p><b>Very rare</b> (less than 0.01%): Cerebrovascular incidents</p><p><b>Frequency not reported</b>: Syncope, ataxia, somnolence</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Paresthesia, lightheadedness, vertigo, dizziness, headache<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Pruritus, rash, alopecia</p><p><b>Uncommon</b> (0.1% to 1%): Angioedema</p><p><b>Very rare</b> (less than 0.01%): Urticaria, Stevens-Johnson syndrome, erythema multiforme, photosensitivity, pemphigoid reactions, erythroderma, exfoliative dermatitis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Cutaneous vasculitis, photosensitivity reactions, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, urticaria, toxic epidermal necrolysis, purpura<sup>[Ref]</sup></p><h3>Other</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Chest pain, malaise, fatigue</p><p><b>Very rare</b> (less than 0.01%): Gynecomastia, fever</p><p><b>Frequency not reported</b>: Asthenia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Fever, weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Tachycardia, palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Tachyarrhythmia, angina pectoris, hypotension, Raynaud's syndrome, flush, pallor, myocardial infarction, congestive heart failure</p><p><b>Very rare</b> (less than 0.01%): Cardiac arrest, cardiogenic shock</p><p><b>Frequency not reported</b>: Rhythm disturbances, orthostatic hypotension</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Postural hypotension, cardiac arrhythmias, vasculitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Cough, dyspnea</p><p><b>Very rare</b> (less than 0.01%): Bronchospasm, rhinitis, allergic alveolitis/eosinophilic pneumonia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Sleep disorders, insomnia</p><p><b>Very rare</b> (less than 0.01%): Confusion, depression</p><p><b>Frequency not reported</b>: Nervousness</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Restlessness, depression, sleep disturbances<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Proteinuria</p><p><b>Uncommon</b> (0.1% to 1%): Polyuria, oliguria, urinary frequency</p><p><b>Very rare</b> (less than 0.01%): Impotence</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Glycosuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Captopril:</p><p><b>Common</b> (1% to 10%): Anorexia</p><p><b>Very rare</b> (less than 0.01%): Hyperkalemia, hypoglycemia, serum potassium increased, serum sodium decreased</p><p><b>Frequency not reported</b>: Symptomatic hyponatremia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anorexia, hyperglycemia, hyperuricemia, electrolyte imbalance, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased, loss of appetite<sup>[Ref]</sup></p><h3>Renal</h3><p>Captopril:</p><p><b>Uncommon</b> (0.1% to 1%): Renal insufficiency, renal failure, nephrotic syndrome</p><p><b>Very rare</b> (less than 0.01%): BUN increased, serum creatinine increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Renal dysfunction, interstitial nephritis<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Captopril:</p><p><b>Uncommon</b> (0.1% to 1%): Eosinophilia</p><p><b>Very rare</b> (less than 0.01%): Neutropenia/agranulocytosis, pancytopenia, anemia, thrombocytopenia, lymphadenopathy, hemoglobin decreased, hematocrit decreased, leukocytes decreased, thrombocytes decreased, erythrocyte sedimentation rate increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Leukopenia, neutropenia/agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, bone marrow depression<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Captopril:</p><p><b>Uncommon</b> (0.1% to 1%): Antinuclear antibody positive</p><p><b>Very rare</b> (less than 0.01%): Autoimmune diseases</p><p><b>Frequency not reported</b>: Anaphylactoid reactions</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Captopril:</p><p><b>Very rare</b> (less than 0.01%): Impaired hepatic function and cholestasis including jaundice, hepatitis including necrosis, elevated liver enzymes and bilirubin</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Captopril:</p><p><b>Very rare</b> (less than 0.01%): Myalgia, arthralgia</p><p><b>Frequency not reported</b>: Myasthenia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Ocular</h3><p>Captopril:</p><p><b>Very rare</b> (less than 0.01%): Blurred vision</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Xanthopsia, transient blurred vision, acute myopia, secondary acute angle-closure glaucoma<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Capozide (hydrochlorothiazide-captopril)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Capozide 50 / 15 (captopril / hydrochlorothiazide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: ACE inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Heart Failure</li>
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>